Oral calcitonin IND filed with FDA

Published: 3-Feb-2001


Novartis has filed an IND application with the US FDA for human clinical testing of salmon calcitonin tablets for the treatment of osteoporosis. The formulation has been developed using Emisphere's oral drug delivery technology.

You may also like